Neurocrine Biosciences
NBIX
#1585
Rank
HK$101.96 B
Marketcap
HK$1,016
Share price
-0.77%
Change (1 day)
18.54%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : HK$10.79 Billion

According to Neurocrine Biosciences 's latest financial reports the company's total liabilities are HK$10.79 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Neurocrine Biosciences - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31HK$10.72 B22.36%
2024-12-31HK$8.76 B10.09%
2023-12-31HK$7.96 B54.18%
2022-12-31HK$5.16 B-5.19%
2021-12-31HK$5.44 B15.46%
2020-12-31HK$4.71 B-9.48%
2019-12-31HK$5.21 B29.87%
2018-12-31HK$4.01 B15.29%
2017-12-31HK$3.48 B793.88%
2016-12-31HK$0.38 B-0.19%
2015-12-31HK$0.39 B46.48%
2014-12-31HK$0.26 B0.23%
2013-12-31HK$0.26 B-17.61%
2012-12-31HK$0.32 B-46.96%
2011-12-31HK$0.60 B-37.53%
2010-12-31HK$0.97 B87.75%
2009-12-31HK$0.51 B-17.59%
2008-12-31HK$0.62 B-48.92%
2007-12-31HK$1.23 B111.25%
2006-12-31HK$0.58 B-19.16%
2005-12-31HK$0.72 B-25.99%
2004-12-31HK$0.97 B-23.27%
2003-12-31HK$1.26 B285.1%
2002-12-31HK$0.32 B17.61%
2001-12-31HK$0.28 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
HK$905.80 B 8,289.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$1.069 T 9,802.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$673.20 B 6,134.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
HK$6.58 B-39.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
HK$0.34 B-96.82%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
HK$7.06 B-34.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
HK$64.37 M-99.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
HK$77.59 B 618.65%๐Ÿ‡ฌ๐Ÿ‡ง UK